FDA Unveils Six-Part Toxicology Roadmap to Expand Predictive Capabilities
By Zachary Brennan -
Published 06 December 2017
The US Food and Drug Administration’s (FDA) Toxicology Working Group this week laid out a six-part roadmap to help the agency better evaluate new methodologies and technologies for their potential to expand FDA’s toxicology predictive capabilities and to potentially reduce the use of animal testing.
Categories: News, US, FDA, Drugs, Preclinical, Regulatory intelligence
Tags: toxicology, FDA toxicology working group